LEADER 03859nam 22006015 450 001 9910881097603321 005 20250808083231.0 010 $a9783031633669$b(electronic bk.) 010 $z9783031633652 024 7 $a10.1007/978-3-031-63366-9 035 $a(MiAaPQ)EBC31608974 035 $a(Au-PeEL)EBL31608974 035 $a(CKB)34118609500041 035 $a(DE-He213)978-3-031-63366-9 035 $a(EXLCZ)9934118609500041 100 $a20240820d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAcute Myeloid Leukemia in Children $eStandard of Care and Future Perspectives /$fedited by Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt 205 $a1st ed. 2024. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2024. 215 $a1 online resource (334 pages) 225 1 $aPediatric Oncology,$x2191-0812 311 08$aPrint version: Tomizawa, Daisuke Acute Myeloid Leukemia in Children Cham : Springer,c2024 9783031633652 320 $aIncludes bibliographical references. 327 $a Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML -- Chromosomal and Genomic Alterations in Pediatric AML -- Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML -- Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML -- Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma) -- Acute Promyelocytic Leukemia -- Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM) -- Myeloproliferative Disorders in Non-Down Syndrome Patients -- AML in Specific Age Groups (Infants. Adolescents and Young Adults) -- Myeloid Neoplasms Post Cytotoxic Therapy in Children -- Advanced MDS in Children -- Relapsed/Refractory AML in Children and Evolution of Novel Therapies -- Stem Cell Transplantation/Cellular and Immunotherapies -- Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML -- Cardiotoxicity in Pediatric AML -- Late effects in Pediatric AML Survivors. 330 $aThis book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners. 410 0$aPediatric Oncology,$x2191-0812 606 $aHematology 606 $aOncology 606 $aPediatrics 606 $aHematology 606 $aOncology 606 $aPediatrics 615 0$aHematology. 615 0$aOncology. 615 0$aPediatrics. 615 14$aHematology. 615 24$aOncology. 615 24$aPediatrics. 676 $a616.99419 702 $aTomizawa$b Daisuke 702 $aKolb$b Edward Anders 702 $aReinhardt$b Dirk 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910881097603321 996 $aAcute Myeloid Leukemia in Children$94207480 997 $aUNINA